Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026
Elutia (NASDAQ: ELUT) will release its fourth quarter 2025 financial results after market close on Wednesday, March 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Elutia (NASDAQ: ELUT) will release its fourth quarter 2025 financial results after market close on Wednesday, March 11, 2026. Management will host a conference call and webcast the same day at 5:00 p.m. ET / 2:00 p.m. PT.
A live and archived webcast will be available in the Investors section at http://investors.elutia.com/. Registered participants receive dial-in details and a PIN, and the system can dial out when the call begins.
Details
News Market Reaction – ELUT
On Feb 26, the first trading day after this news, ELUT closed 5.50% above the previous close.
Data tracked by StockTitan Argus for the Feb 26 session.
Key Figures
- Earnings period
- Fourth quarter 2025
- Period for upcoming financial results
- Earnings date
- March 11, 2026
- Scheduled release after market close
- Conference call time ET
- 5:00 p.m. Eastern Time
- Start time of management call
- Conference call time PT
- 2:00 p.m. Pacific Time
- Start time of management call
- Log-in lead time
- 10 minutes
- Recommended time before webcast start
Historical Context
-
Great Place to Work 2026 certification and culture highlights.
-
Preliminary Q4 2025 results, asset-sale proceeds, and NXT-41x milestones.
-
NXT-41x program presentation at Global BioInnovation Forum.
-
Q3 2025 results and $88M BioEnvelope sale to Boston Scientific.
-
Announcement of Q3 2025 earnings release date and conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter 2025 financial results after market close on Wednesday, March 11, 2026. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
Dial-In: Click here
To receive the dial-in number, as well as your personalized PIN, you must register at the above link. Once registered, you will also have the option to have the system dial-out to you once the conference call begins. If you forget your PIN prior to the conference call, you can simply re-register.
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Elutia Investor Relations
ir@elutia.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.